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Abstract
The anaphase-promoting complex or cyclosome (APC/C) is a multi-subunit ubiquitin ligase that regulates exit from mitosis
and G1 phase of the cell cycle. Although the regulation and function of APC/C
Cdh1 in the unperturbed cell cycle is well
studied, little is known of its role in non-genotoxic stress responses. Here, we demonstrate the role of APC/C
Cdh1 (APC/C
activated by Cdh1 protein) in cellular protection from endoplasmic reticulum (ER) stress. Activation of APC/C
Cdh1 under ER
stress conditions is evidenced by Cdh1-dependent degradation of its substrates. Importantly, the activity of APC/C
Cdh1
maintains the ER stress checkpoint, as depletion of Cdh1 by RNAi impairs cell cycle arrest and accelerates cell death
following ER stress. Our findings identify APC/C
Cdh1 as a regulator of cell cycle checkpoint and cell survival in response to
proteotoxic insults.
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Introduction
The APC/C is a multimeric ubiquitin ligase that regulates the
progression of mitosis and establishment of G1 in the cell cycle
through sequential activation by the substrate-adaptors/activators
Cdc20 and Cdh1 [1]. APC/C
Cdc20 initiates anaphase and mitotic
exit by targeting securin and mitotic cyclins for ubiquitination and
subsequent proteasomal degradation. The switch from APC/
C
Cdc20 to APC/C
Cdh1 in late mitosis continues the destruction of
mitotic proteins including cyclin B1, Cdc20, Polo-like kinase 1
(Plk-1), and Aurora B to complete mitosis and establish G1.
Sequential activation of APC/C
Cdc20 and APC/C
Cdh1 depends on
their differential regulation by the mitotic cyclin-dependent kinases
(CDKs): CDK-dependent phosphorylation of several subunits of
the APC/C core promotes association with Cdc20, whereas
phosphorylation of Cdh1 inhibits its binding to the APC/C core
[2,3]. This renders APC/C
Cdc20 active in mitosis when CDK
activities are high and APC/C
Cdh1 active in telophase when CDK
activities decline. Opposing the CDK-mediated inhibitory phos-
phorylation on Cdh1 is the phosphatase Cdc14 [3,4]. In addition,
binding of inhibitors like Emi1 (early mitotic inhibitor 1) from the
G1-S transition to G2 or Rae1 (RNA export 1 homologue) in early
mitosis restricts the activity of the APC/C [5,6,7].
The APC/C is not only a critical regulator of the cell cycle but
also a key component of checkpoint signaling that can modulate
cell cycle progression in response to internal and external stimuli.
In an unperturbed cell cycle, APC/C
Cdc20 is a target of the spindle
assembly checkpoint (SAC), which inhibits chromosomal segrega-
tion until all sister chromatids are properly attached to the mitotic
spindle [8]. Under cellular stress conditions, however, there is little
evidence for checkpoint-dependent regulation of the APC/C. A
few studies have reported the control of APC/C by genotoxic
stress in mammalian cells. Ionizing radiation was shown to activate
the APC/C to degrade cyclin D1, which triggers an immediate
p53-independent G1 arrest [9]. DNA damage incurred in G2 has
also been reported to activate APC/C
Cdh1, which specifically
targets Plk-1 for degradation and results in G2 arrest through the
stabilization of Claspin [4,10]. In the latter case, DNA damage-
induced translocation of Cdc14B from the nucleolus to the
nucleoplasm is implicated in the activation of APC/C
Cdh1 in G2.
Additionally, UV radiation triggers proteolysis of Cdh1, leading to
the accumulation of cyclin B1 that promotes apoptosis [11]. While
these findings from mammalian cells support the role of APC/C as
an effector of checkpoint response to cellular stress, they are
limited to the context of DNA damage. In contrast, APC/C
Cdh1 in
Saccharomyces cerevisiae is required for proper stress response to
hyperosmotic shock and activation of the cell wall integrity
pathway [12], prompting the question of whether cellular stresses
other than DNA damage may also engage the APC/C in cell cycle
checkpoint control in mammalian cells.
In this study, we explored the possible role of APC/C in
regulating cell cycle response to ER stress. ER stress occurs when
ER function is perturbed, which can result from physiological
fluctuations in protein synthesis, pathological accumulation of
misfolded proteins, or alterations in calcium levels or the redox
state in the ER [13]. Three transmembrane proteins act as sensors
of ER dysfunction: PERK (protein kinase RNA (PKR)-like ER
kinase), IRE1 (inositol-requiring enzyme 1), and ATF6 (activating
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action of these proteins initiate the unfolded protein response
(UPR) to augment the protein folding capacity of the ER by
coordinately attenuating protein synthesis through global inhibi-
tion of translation, increasing transcription of protein chaperones,
and removing unfolded/misfolded proteins by transcriptional
activation of regulators of ER-associated degradation (ERAD)
[14], all of which serve to restore homeostasis in the ER. When
this adaptive program is insufficient to restore ER function,
apoptosis is often induced [15]. In addition, in mammalian cells,
ER stress also activates the ER stress checkpoint to delay cell cycle
progression through G1, by downregulation of cyclin D1 through
PERK-mediated translational repression and proteolysis
[16,17,18] or transcriptional induction of p21 via PERK-
dependent stabilization of p53 [19]. Both the cyclin D1- and
p53-dependent checkpoint responses converge at the inactivation
of CDK2 by the CDK inhibitor p21 to delay G1 progression.
Intriguingly, p53-deficient HeLa cells still exhibit G1 arrest in
response to ER stress that cannot be overcome by the
overexpression of cyclin D1 [20], indicating the presence of p53-
and cyclin D1-independent pathways in the control of the ER
stress checkpoint. We recently identified one such pathway
involving the accumulation of p27, also an inhibitor of CDK2,
as a result of reduced deubiquitination and transcriptional
downregulation of Skp2 [20]. Our findings also suggested the
existence of additional cell cycle components that contribute to the
ER stress checkpoint.
Here, we identify APC/C
Cdh1 activity as a key component of
the p53- and cyclin D1-independent ER stress checkpoint pathway
that delays cell cycle progression through G1. ER stress-dependent
activation of APC/C
Cdh1 is required to coordinate cell cycle delay,
and depletion of Cdh1 sensitizes cells to apoptosis under ER stress
conditions. Collectively, our findings not only indicate that APC/
C
Cdh1 is a regulator of checkpoint signaling and cell viability in
response to proteotoxicity, while unveiling the potential of the
APC/C to mediate a range of stress-induced checkpoint responses
wider than previously anticipated.
Results
APC/C
Cdh1 is activated under ER stress conditions
When we analyzed the cell cycle response to ER stress in HeLa
cells by treatment with tunicamycin (TM), a pharmacological ER
stress inducer that inhibits glycosylation of newly synthesized
glycoproteins, we observed a marked reduction in the protein
levels of endogenous cyclins A and B1, Cdc20, and Plk-1 –all of
which are known substrates of the APC/C
Cdh1 [1] (Figure 1A). To
determine whether such changes in expression occur transcrip-
tionally or post-translationally, we compared the kinetics of
downregulation at the mRNA and protein levels. We found that
while transcriptional repression likely participated in the reduction
of APC/C
Cdh1 substrates under prolonged TM treatment
(Figures 1B-bottom graphs and S1), protein downregulation
occurred at a faster rate than transcriptional repression of these
substrates, as observed at the early time points following TM
treatment (Figures 1A-right panel and 1B). These results suggest
that ER stress downregulates APC/C
Cdh1 substrates both by
protein degradation and transcriptional repression. The ability of
the proteasome inhibitor, MG-132, to block TM-dependent
downregulation of Plk-1 further supports accelerated protein
degradation of APC/C
Cdh1 substrates following ER stress
(Figure 1C, lanes 1–4). The TM-dependent decrease of the cell
cycle proteins examined here was selective and not due to a
general increase in proteasomal activity, as the protein stability of
the cell cycle regulator p27 is prolonged by TM treatment [20].
Taken together, TM-induced protein destabilization of APC/
C
Cdh1 substrates suggests activation of APC/C
Cdh1 under ER
stress conditions.
To determine whether APC/C
Cdh1 is responsible for the
degradation of its substrates under ER stress conditions, we next
tested if depletion of Cdh1 could overcome TM-dependent
downregulation of its substrates. Cdh1 knockdown by RNAi
(Cdh1-KD) alone attenuated TM-induced reduction of Plk-1
(Figure 1C, lanes 9–12; & data below) and cyclin A (see data
below), supporting the hypothesis that APC/C
Cdh1 is activated
following ER stress induction. Depletion of Cdh1, however, did
not fully reverse downregulation of its substrates probably due to
TM-dependent transcriptional repression.
Curiously, TM treatment also reduced Cdh1 expression
(Figures 1A and 1B) solely by protein degradation, as no change
in the transcription of Cdh1 (Figures 1B and S1) but rather a
steady decrease in both the endogenous and exogenous Cdh1
protein levels was observed (Figures 1B and S2A, respectively). In
addition, MG-132 restored Cdh1 protein levels upon TM
treatment (Figure 1C, lanes 1–4). To test whether ER stress
triggers auto-ubiquitination of Cdh1 by APC/C
Cdh1 [21], we
depleted the APC/C core subunit —Cdc27/APC3— by RNAi
and examined its effect on TM-induced downregulation of Cdh1.
To our surprise, knockdown of Cdc27 did not restore the levels of
Cdh1 following TM treatment (Figure S2B), suggesting that while
TM treatment enhances APC/C
Cdh1 activity, it also induces
degradation of Cdh1 by an ubiquitin ligase other than the APC/
C.
Depletion of Cdh1 overcomes ER stress-induced G1 delay
Having shown that ER stress activates APC/C
Cdh1, we next
sought to determine whether APC/C
Cdh1 activity is required for
the cell cycle response to ER stress, in particular, the G1 ER stress
checkpoint [17,20]. We treated asynchronous control-transfected
or Cdh1-KD cells with TM for 8 h or 16 h and analyzed cell cycle
distribution by fluorescence activated cell sorting (FACS). ER
stress delayed progression through G1 in a time-dependent
manner (Figures 2A-graph, 2B-graph, S3A, and S3B) as previously
shown [17,20]. Depletion of Cdh1 largely overcame this effect,
reducing the TM-induced G1 increase from 8 and 15% at 8 h and
16 h respectively in control cells to 1 and 3% in the Cdh1-KD cells
(Figures 2A, 2B, and S3A and S3B). These findings support the
Figure 1. APC/C
Cdh1 is activated under ER stress conditions. (A) Left, HeLa cells were treated with DMSO or 2.5 mg/ml of tunicamycin (TM) for
8 h. Total cell lysates were immunoblotted for the indicated endogenous proteins. GRP78 served as a marker of ER stress. Right, HeLa cells were
harvested at the indicated times after addition of DMSO or 2.5 mg/ml of TM. Total cell lysates were immunoblotted for the indicated endogenous
proteins. HSP90 was used as a loading control. (B) HeLa cells were treated with DMSO or 1 mg/ml of tunicamycin for the indicated times. Immunoblots,
total cell lysates were immunoblotted for the indicated endogenous proteins. Graphs, transcript levels as measured by SYBR-green qRT-PCR and
protein levels as quantified by LiCOR-Odyssey software on immunoblots are compared for the indicated proteins. All measurements were normalized
to the DMSO-0 h sample with relative value of 1. (C) HeLa cells were transfected with pSUPER (empty vector) or pSUPER-Cdh1-shRNA (Cdh1-KD). 24 h
after transfection, cells were treated with DMSO, 1 mg/ml of TM alone, or 1 mg/ml of TM plus MG-132 (2 or 5 mM) for 16 h. Total cell extracts were
immunoblotted for the indicated endogenous proteins.
doi:10.1371/journal.pone.0035520.g001
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Cdh1 activity in the establishment and/or
maintenance of ER stress-dependent G1 delay.
Mechanisms supporting APC/C
Cdh1 activity under ER
stress
To explore possible mechanisms that contribute to APC/C
Cdh1
activation following TM treatment, we examined several param-
eters. First, because complex formation between the APC/C core
and Cdh1 is a prerequisite for APC/C
Cdh1 activation, we tested
whether ER stress promotes APC/C
Cdh1 assembly. Surprisingly,
although TM reduced Cdh1 protein levels (Figure 1A), it
enhanced the association between endogenous Cdh1 and the
APC/C core subunit Cdc27/APC3 (Figure 3A, compare lanes 4
and 5) concomitant with induction of G1 arrest (Figure S4A).
Addition of MG-132 reversed the effect of TM on APC/C
Cdh1
assembly (Figure 3A, compare lanes 4–6), despite the fact that
MG-132 treatment stabilized the Cdh1 protein (Figures 1C and
3A). The inhibitory effect of MG-132 on complex formation of
APC/C
Cdh1 likely results from its ability to arrest the cell cycle in
G2/M (Figures S4B and S4C), in which high mitotic Cdk activity
blocks Cdh1 binding to the APC/C core [3,22,23]. This
observation reveals that the Cdh1 protein level does not always
positively correlate with the abundance of active APC/C
Cdh1
complexes.
Since CDK-dependent phosphorylation of Cdh1 inhibits the
assembly of APC/C
Cdh1, in part by localizing Cdh1 to the
cytoplasm, we next examined CDK1 and CDK2 activities in TM-
treated HeLa cells. Using in vitro kinase assays, we found both
activities to be reduced by TM treatment (Figure 3B), suggesting
that reduced inhibitory phosphorylation of Cdh1 may also
contribute to promote APC/C
Cdh1 complex formation following
induction of ER stress.
Furthermore, APC/C is also controlled by association with
proteins that inhibit its activation and/or assembly. Emi1 is an
APC/C inhibitor that acts by competitive binding to APC/C
Cdh1
as a pseudosubstrate [5,6]. The transcription factor E2F induces
Emi1 transcription at the G1-S transition, which results in
inhibition of APC/C
Cdh1 that promotes G1 exit [24]. Upon
examining the expression of Emi1, we found that TM treatment
drastically decreased the protein levels of Emi1 (Figures 1C and
3C, Left). This was not a result of transcriptional repression
(Figure 3C, Right), but rather a result of proteasomal degradation
that could be rescued by MG-132 (Figure 1C, lanes 1–4). To test
the possibility that ER stress conditions may convert Emi1 from a
pseudosubstrate into a bona fide substrate of APC/C
Cdh1,w e
Figure 2. Depletion of Cdh1 overcomes ER stress-induced G1 delay. (A) Empty vector-transfected and Cdh1-KD HeLa cells were treated with
DMSO or 2.5 mg/ml of TM for 8 h. Left, knockdown efficiency was verified by immunoblotting of endogenous Cdh1. Right, cell cycle distribution of the
same cells was analyzed by FACS. Graph quantifies the increase in percentage of cells in G1 after treatment with 2.5 mg/ml of TM for 8 h, normalized
to the percentage in DMSO-treated samples. (B) Empty vector-transfected and Cdh1-KD cells were then treated with DMSO or 1 mg/ml of TM for 16 h.
Left, knockdown efficiency was verified by immunoblotting of endogenous Cdh1. Right, graph quantifies the increase in percentage of cells in G1
after treatment with 1 mg/ml of TM for 16 h, normalized to the percentage in DMSO-treated samples.
doi:10.1371/journal.pone.0035520.g002
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depleted cells. We observed no difference in the degree of ER
stress-dependent Emi1 downregulation between control and
Cdh1-KD cells (Figures 1C, lanes 9–10 and S5), arguing against
a role for the APC/C
Cdh1 in Emi1 degradation under ER stress
conditions. Finally, overexpression of Emi1 partially blocked the
TM-induced downregulation of APC/C
Cdh1 substrates (Figure
S6), suggesting that ER stress-dependent Emi1 downregulation
Figure 3. Mechanisms supporting APC/C
Cdh1 activity under ER stress conditions. (A) HeLa cells were treated with DMSO, 0.5 mg/ml of TM
alone, or 0.5 mg/ml of TM plus 5 mM of MG-132 for 16 h. Immunoprecipitates of endogenous Cdc27 were immunoblotted for endogenous Cdh1.
Immunoprecipitation using IgG served as negative control. ** indicates Cdh1-specific top band; *indicates non-specific bottom band. (B) HeLa cells
were treated with DMSO or 1 mg/ml of TM for 16 h. CDK2 or CDK1 antibodies were used to immunoprecipitate endogenous CDK2 or CDK1
complexes, respectively. Immunoprecipitates were then used in in vitro kinase assays using histone H1 as substrate. Left, autoradiography of
32P-
histone H1 phosphorylated by CDK2 complexes. Coomassie stains input of histone H1 in the reactions. Intensity of the autoradioactive bands were
quantified by Image J, normalized to histone H1 input, and presented as arbitrary units (A.U.). Immunoblot shows comparable levels of endogenous
CDK2 and the indicated proteins before and after TM treatment. Right, autoradiography of
32P-histone H1 phosphorylated by CDK1 complexes,
analyzed as indicated for CDK2. (C) Left, total cell lysates from HeLa cells treated with DMSO or 1 mg/ml of TM for 16 h were immunoblotted for the
indicated endogenous proteins. Right, quantification of endogenous Emi1 mRNA levels in HeLa cells treated with DMSO or 1 mg/ml of TM for 16 h,
measured by SYBR-green qRT-PCR.
doi:10.1371/journal.pone.0035520.g003
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Cdh1 activity. Taken together, cellular ER stress
ensures APC/C
Cdh1 activation through multiple mechanisms
including enhanced affinity between Cdh1 and subunits of the
APC/C core, reduced activity of CDKs, and Emi1 downregula-
tion. Although the mechanisms examined above support APC/
C
Cdh1 activity, it is unclear whether they are the initiating events
that activate APC/C
Cdh1 in response to ER stress or the
consequence of ER stress-induced G1 phase delay.
Cdh1 depletion sensitizes cells to ER stress-induced cell
death
APC/C
Cdh1 has been reported to target the ER stress-induced
pro-apoptotic proteins c-Jun N-terminal kinase (JNK) and tribbles-
related protein 3 (TRB3) for ubiquitin-proteasome degradation
[25,26,27,28]. Our finding that APC/C
Cdh1 becomes active
following ER stress induction raises the possibility that APC/
C
Cdh1 may exert a pro-survival effect under such conditions. To
test this, we compared the susceptibility of control and Cdh1-KD
cells to TM-induced cell death upon TM treatment by
immunoblotting for cleaved PARP, a marker of apoptosis resulting
from cleavage by the pro-apoptotic protease caspase 3 [29,30].
Cleaved PARP was strongly induced by 24 h after TM treatment
in both control-transfected and Cdh1-KD cells, but was detectable
as early as 9 h after treatment only in Cdh1-KD cells (Figure 4A).
Because prolonged Cdh1-KD adversely affected basal cell viability
(Figure 4A, compare lanes 9 and 13), we compared cell survival of
TM-treated control and Cdh1-KD cells at the shorter time-point
of 12 h and again found increased sensitivity of Cdh1-KD cells to
apoptosis at 9 h and 12 h of treatment (Figure 4B). Enhanced
susceptibility to cell death was also seen in Cdh1-KD cells after
treatment with another ER stress inducer, the disulfide bond-
reducing agent dithiothreitol (DTT) (Figure 4C).
Additionally, we measured the DNA content by flow cytometry
in order to quantify apoptotic cells, which have diminished DNA
content and appear as a sub-G1 population. Quantification of the
sub-G1 population showed a more than two-fold increase in cell
death in Cdh1-KD compared with the control cells at 12 h of TM
treatment (Figure 4D, representative FACS histograms in Figure
S7). Taken together, these data show that Cdh1-KD accelerates
ER stress-induced cell death between 9 h and 24 h after TM
treatment; however, extended depletion of Cdh1 alone compro-
mises overall cell survival. A similar pattern of cell death was found
after DTT treatment (Figure 4D).
In a more detailed comparison of the kinetics of TM-induced
cell death in control and Cdh1-KD cells, we again observed
enhanced apoptosis in Cdh1-KD cells between 12 h and 24 h of
treatment, with evident PARP cleavage in Cdh1-KD cells but not
in the control (Figure 5A, Top immunoblot panels), and increased
sub-G1 population in Cdh1-KD cells (Figure 5A, Bottom graph).
Notably, the protein expression of APC/C
Cdh1 substrates such as
Plk-1 and cyclin A was prolonged in TM-treated Cdh1-KD cells
compared to the TM-treated control (Figure 5A, Top panels).
Finally, examination of DNA strand breaks by TdT-mediated
dUTP nick end labeling (TUNEL) revealed that twice as many
TM-treated Cdh1-KD cells were TUNEL-positive as TM-treated
control cells (Figure 5B), consistent with our findings from
detection of apoptosis based on PARP cleavage and sub-G1
quantification. Taken together, the concurrent deregulation of cell
cycle response and sensitization to cell death in Cdh1-KD cells
under ER stress conditions suggest a pro-survival role for the
APC/C
Cdh1-dependent ER stress checkpoint.
We next sought to identify downstream effector(s) of ER stress-
induced apoptosis in the absence of Cdh1. JNK and the CDK1-
activating subunit cyclin B1 are two appealing candidates because
both are substrates of the APC/C
Cdh1 [28,31] with pro-apoptotic
functions [32,33]. To examine this, control and Cdh1-KD cells
were monitored for cell death by PARP cleavage and DNA
content after co-treatment with TM and either the JNK inhibitor
SP600125 [34] or the pan-CDK inhibitor roscovitine [35] for 8,
12, and 24 h. We found increased cell death in both cell types at
all time points after co-treatment of TM and SP600125, compared
with TM treatment alone (Figure S8, Left graph). In contrast, co-
treatment with roscovitine reduced cell death of both control and
Cdh1-KD cells by almost 50% at 24 h, but not at earlier time-
points (Figure S8, Right graph). These results point to the
involvement of CDKs in mediating cell death under prolonged
ER stress conditions (24 h in TM). However, the inability of
roscovitine to rescue cell death at earlier time points, when Cdh1-
KD specifically enhances TM-dependent apoptosis, suggests that
the activity from CDKs is not responsible for the accelerated ER
stress-induced cell death in the absence of Cdh1 (Figure S8).
Altogether, these data suggest that neither JNK nor CDKs
mediate the death of Cdh1-KD cells under ER stress conditions.
Discussion
Our study provides evidence for activation of APC/C
Cdh1
under ER stress conditions with concomitant downregulation of
the APC/C inhibitor Emi1 and enhanced interaction between
Cdh1 and the APC/C core subunits. At present, it is not clear
whether these events activate APC/C
Cdh1 in response to ER stress
to initiate cell cycle arrest or are a consequence of ER stress-
induced cell cycle delay. In either case, the activity of APC/C
Cdh1
was found to positively regulate the ER stress checkpoint:
depletion of Cdh1 by RNAi partially rescued TM-induced
degradation of APC/C
Cdh1 substrates as well as G1 delay. It
remains to be determined whether the activity of APC/C
Cdh1 is
involved in the establishment or maintenance of such cell cycle
response.
Our observations that TM triggers protein destabilization of
Cdh1 and Emi1 raise the question of what ubiquitin ligases target
them for degradation under such conditions. It is also formally
possible that ER stress translationally represses Cdh1 and Emi1.
The requirement for APC/C
Cdh1 in the engagement of the ER
stress checkpoint is independent of that for p53 and cyclin D1, but
reinforces the previously identified Ufd1-USP13-Skp2-p27 axis
[20]: as the decline in Ufd1 reduces the deubiquitination of Skp2,
APC/C
Cdh1 is concurrently activated to ubiquitinate Skp2 and its
other substrates. However, the cyclin D-, p53-, and APC/C
Cdh1-
dependent pathways may not be mutually exclusive in establishing
and/or maintaining the ER stress checkpoint, as the downregu-
lation of APC/C
Cdh1 substrates at the protein level was also
detected in normal human foreskin fibroblasts with intact p53
(Figure S9). This suggests establishment of the ER stress
checkpoint through the coordinated regulation of multiple cell
cycle pathways.
In addition to bypassing the checkpoint response, Cdh1-
depleted cells were more sensitive to ER stress-induced apoptosis,
underscoring the pro-survival function of APC/C
Cdh1 under such
conditions and supporting the G1 ER stress checkpoint as a pro-
survival mechanism to cope with proteotoxic conditions. The
latter implication is consistent with our previous finding that G1
phase of the cell cycle promotes degradation of ERAD substrates
[20]. If it is halting cell cycle progression that is critical for cell
survival under ER stress, then it is likely that induction of the
entire degradation program of APC/C, rather than degradation of
any single substrate, is required for viability in response to ER
stress.
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CHOP (C/EBP homologous protein) by mechanisms that include
IRE1-dependent recruitment of TRAF2 (tumor necrosis factor
receptor-associated factor 2) leading to activation of JNK [36] and
CHOP-dependent suppression of the pro-survival protein Bcl-2
[37]. Here, we describe previously unrecognized roles for cell cycle
Figure 4. Cdh1 depletion sensitizes cells to ER stress-induced cell death. (A) Empty vector-transfected or Cdh1-KD cells were treated with
DMSO or 0.5, 1, or 2 mg/ml of TM for 9 h or 24 h. Total cell lysates were immunoblotted for cleaved PARP and indicated endogenous proteins. (B)
Empty vector-transfected or Cdh1-KD cells were treated with DMSO, 0.5 mg/ml, or 1 mg/ml of TM for 9 h or 12 h. Total cell lysates were analyzed as in
(A). (C) Empty vector-transfected or Cdh1-KD cells were treated with solvent (mock) or 1–3 mM DTT for 9 h or 12 h. Total cell lysates were
immunoblotted as in (A). (D) Left, empty vector-transfected or Cdh1-KD cells were collected at 9, 12, and 24 h after treatment with DMSO or 0.5 mg/ml
of TM for DNA content analysis by flow cytometry. Graph shows percentage of sub-G1 population at each time point. Right, empty vector-transfected
or Cdh1-KD cells were collected at 9, 12, and 24 h after treatment with solvent (mock) or 1 mM DTT for DNA content analysis by flow cytometry.
Graph shows percentage of sub-G1 population at each time point.
doi:10.1371/journal.pone.0035520.g004
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APC/C
Cdh1 that provides initial protection against apoptosis and
the cyclin-CDK activities that contribute to cell death under
prolonged ER stress conditions.
There are several implications for the identification of the APC/
C
Cdh1 as a key regulator of checkpoint response and cell survival
under ER stress. First, the repertoire of stress conditions that
engage the APC/C
Cdh1 in coordinating the cell cycle response is
no longer limited to genotoxic stress in mammalian cells. Indeed,
based on our findings, any condition that disrupts ER homeostasis
may regulate APC/C
Cdh1, including alterations in metabolic
conditions, redox states, and/or intracellular calcium concentra-
tions [38]. Second, the pro-survival role of APC/C
Cdh1 under ER
stress conditions first identified here suggests that APC/C
Cdh1 may
act as a switch that determines cell fate in response to ER stress.
Finally, given the widely recognized link between chronic ER
stress-induced apoptosis and human diseases such as neurodegen-
eration and diabetes [39], our current findings suggest that cell
cycle proteins may be effectors in the pathogenesis of these diseases
and possible therapeutic targets for diseases characterized or
accompanied with ER stress.
Materials and Methods
Cell culture and transfection
HeLa [human cervical adenocarcinoma epithelial] cells [27]
were grown in DMEM with 10% bovine serum at 37uC with 5%
CO2. Human foreskin fibroblasts (HFF-1) were grown in DMEM
with 10% fetal bovine serum. All cell lines were obtained from the
American Type Culture Collection (ATCC) and tested free of
mycoplasma during the complete experimental phase of the
project. For transient transfection of plasmids in HeLa cells, 80%-
confluent cells grown in 10 cm dishes were transfected with 5 mg
of each of the indicated plasmids, using Lipofectamine 2000
(Invitrogen) following manufacturer’s protocols.
Expression plasmids
pSUPER-empty vector and pSUPER-Cdh1-shRNA were
generous gifts from Dr. Reuven Agami (The Netherlands Cancer
Institute, Amsterdam, Netherlands). Both pCS2+-myc empty
vector and pCS2+-myc-Emi1 were generous gifts from Dr. Peter
K. Jackson (Genentech, San Francisco, USA). pCMV-myc-Cdh1
was used to overexpress Cdh1 in HeLa cells [28].
shRNA target sequence
pSUPER-Cdh1-shRNA: TGAGAAGTCTCCCAGTCAG –
previously published [40].
Antibodies
Commercially available antibodies used in this study were:
Cdh1 (DCS-266– Abcam at 1:1000 dilution), cyclin B1 (GNS1–
Santa Cruz at 1:1000), cyclin A (H-3– Santa Cruz at 1:1000),
GRP78 (N-20– Santa Cruz at 1:1000), c-myc (9E10– Santa Cruz
at 1:2000), Plk-1 (F-8– Santa Cruz at 1:1000), Cdc20 (ab26483–
Abcam at 1:500), CDK1 (SC-54– Santa Cruz at 1:1000), CDK2
(SC-163– Santa Cruz at 1:1000), cleaved PARP (9541– Cell
Signaling Technology at 1:1000), Emi1 (37-6600– Invitrogen at
1:500), Cdc27 (AF3.1– Santa Cruz at 1:1000), HSP90 (F-8– Santa
Cruz at 1:1000), a-tubulin (TU-02– Santa Cruz at 1:2000).
Immunoblotting and immunoprecipitation
For western blots of total cell lysates, cells were detached from
plates with 0.05% trypsin-EDTA, washed with cold PBS,
resuspended in IP buffer (50 mM Tris-HCl [pH=7.6], 150 mM
NaCl, 0.5% NP-40, 5 mM EDTA, 5 mM EGTA, 20 mM NaF,
100 mM sodium-orthovanadate, 2 mM b-glycerophosphate,
1 mM DTT, 1 mM PMSF, 4 mg/ml aprotinin, 100 mM leupep-
tin, and 2 mg/ml pepstatin A), and lysed on ice for 20 min.
Lysates were then centrifuged for 20 min (13200 rpm at 4uC),
supernatants were saved, and protein concentration was per-
formed using Coomassie Plus Protein Assay Reagent (Thermo
Scientific) following manufacturer’s recommendations.
For in vivo co-immunoprecipitation, cells were washed with cold
PBS and lysed with IP buffer. Target protein was immunoprecip-
itated from total cell lysates containing 2 mg of protein with 1 mg
of target-specific antibody overnight at 4uC in a rotating wheel,
followed by incubation with 30 ml of 50% slurry of protein G-
agarose for 2 h at 4uC with rotation. Immunoprecipitates were
washed 4 times with IP buffer, resuspended in loading buffer and
analyzed by SDS-PAGE and western blotting.
In vitro kinase assay
Cells were lysed with modified IP buffer (0.1% NP-40, 25 mM
Tris-HCl [pH=7.6], 50 mM NaCl, 5 mM EGTA, 60 mM b-
glycerophosphate, 20 mM NaF, 100 mm sodium-orthovanadate,
1 mM DTT, 1 mM PMSF, 100 mM leupeptin, and 4 mg/ml
aprotinin). Endogenous CDK1 and CDK2 were immunoprecip-
itated from approximately 400 mg of total cell lysate, using 0.5 mg
of CDK2- or CDK1-specific antibody. Immunoprecipitates were
washed 3 times with histone H1 buffer (15 mM MgCl2, 20 mM
EGTA, 80 mM b-glycerophosphate pH 7.4, 1 mM DTT, 1 mM
PMSF, 4 mg/ml aprotinin, and 100 mM leupeptin). Kinase
reactions were performed by incubating pellets with 35 mlo f
histone H1 buffer supplemented with 0.1 mg histone H1, 0.2 ml
32P-cATP and 50 mM unlabeled ATP. Reactions were incubated
for 30 min at 30uC in shaking at 800 rpm and then stopped by
addition of SDS-PAGE sample buffer and heat-denaturation.
Samples were analyzed by SDS-PAGE. Gels were Coomassie-
stained, dried, and exposed to film.
DNA content analysis by fluorescence-activated cell
sorting (FACS)
Cells were washed with cold PBS, fixed with 70% ethanol in
PBS for 1 h at 220uC, and washed again with cold PBS. Cells
were then incubated in PBS containing 50 mg/ml propidium
iodide (PI) and 100 mg/ml RNase A for 1 h at room temperature.
Analysis of DNA content was performed on FACSCanto, using
488 nm excitation. FlowJo and ModFit LT software were used to
analyze cell cycle profile.
For detection of apoptotic cells with reduced DNA content by
FACS, cells were fixed in ethanol as described above, then
subjected to mild extraction of low molecular weight DNA by
Figure 5. Cdh1 depletion sensitizes cells to ER stress-induced cell death. (A) Top, empty vector-transfected or Cdh1-KD cells were collected
at 0, 8, 12, 16, 20, and 24 h after treatment with DMSO or 1 mg/ml of TM. Total cell lysates were immunoblotted for the indicated proteins. DNA
content of these cells was analyzed by flow cytometry. Bottom, graph shows percentage of sub-G1 population at each time point. (B) HeLa cells were
co-transfected with empty vector plus mcherry-H2B, or Cdh1-shRNA plus mcherry-H2B. 24 h after transfection, DMSO or 1 mg TM was added to cells
for 16 h. Fluorescence microscopy was used to visualize the nuclei (by DAPI staining), transfected cells (by mcherry-H2B), and apoptosis-induced DNA
strands breaks (by TUNEL staining). Bottom graph quantifies TUNEL-positive cells.
doi:10.1371/journal.pone.0035520.g005
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30 min at 37uC on a shaker. Cells were then centrifuged and
stained with PI as described above.
TdT-mediated dUTP nick end labeling (TUNEL)
HeLa cells were seeded on coverslips and co-transfected with
6 mg of pSUPER empty vector plus 1 mg of mcherry-H2B, or 6 mg
of pSUPER-Cdh1-shRNA plus 1 mg of mcherry-H2B for 24 h.
Co-transfection with mcherry-H2B enables monitoring of trans-
fection efficiency by fluorescence microscopy. Cells were then
treated with DMSO or 1 mg/ml TM for 16 h, washed with PBS
twice, fixed in 4% paraformaldehyde with 2% sucrose in PBS for
20 min at room temperature. Detection of apoptosis-induced
DNA strand breaks was performed according to the manufactur-
er’s protocol using the In Situ Cell Death Detection Kit, AP (Roche
Applied Sciences), followed by 49,6-diamidino-2-phenylindole
(DAPI) staining of the nuclei. Fluorescein-labeled DNA strand
breaks were examined under a fluorescence microscope with an
excitation wavelength of 450–500 nm (green). 300 mcherry-H2B-
positive cells were counted for quantification of TUNEL-positive
cells under each condition.
SYBR-green qRT-PCR
Total RNA was extracted from cells grown in 10 cm plates
(Sigma-Aldrich, RTN70-1KT). Up to 2 mg of total RNA was used
per 20 ml cDNA reverse transcription reaction (Applied Biosys-
tems, High-Capacity cDNA Reverse Transcription Kit). A 5 ml
aliquot of 20% (vol/vol) diluted cDNA was used per 25 ml of qRT-
PCR with SYBR GreenER qPCR SuperMix Universal (Invitro-
gen) and gene-specific primers. Forty cycles of qPCR and analysis
were performed using Stratagene Mx3000p. Human cyclophilin
was used as a control to normalize transcript levels of experimental
samples. The specificity of all primer sets was validated by
dissociation curves. qPCR primer sequences were as follows:
Cdh1.
Forward - GCAACAAGAGCCAGAAGCTGC
Reverse - CCAGGTTCCCCCGCTCAGACC
Emi1:.
Forward - GGACTTAATCAATGTGTCTAAAG
Reverse - CTTGGCAACCTCAGAGAATTC
Cyclin B1.
Forward - CGGTTCATGCAGAATAATTGTGTGC
Reverse - GTTGCTCGACATCAACCTCTCCAATC
Plk-1.
Forward - GGTCAGGCAAGAGGAGGCTG
Reverse - GGAGGGTGATCTTCTTCATC
Cdc20.
Forward - GCTGTCAAGGCCGTAGCATGG
Reverse - GATGTGTGACCTTTGAGTTC
Cyclophilin.
Forward - GACCCAACACAAATGGTTC
Reverse – AGTCAGCAATGGTGATCTTC
Supporting Information
Figure S1 TM downregulates the transcription of Plk-1,
cyclin B1, and Cdc20. HeLa cells were treated with DMSO or
1 mg/ml TM for 16 h. The mRNA levels of the indicated genes
were quantified by SYBR-green qRT-PCR.
(TIF)
Figure S2 Degradation of Cdh1 during ER stress is not
APC/C-mediated. (A) HeLa cells transfected with myc-Cdh1
were treated with DMSO or 1 mg/ml of TM. Total cell lysates
were collected every 2 h over 10 h and immunoblotted for myc.
(B) HeLa cells transfected with empty vector or Cdc27-specific
shRNA (Cdc27-KD) were treated with DMSO or 1 mg/ml of TM
for the indicated times. Total cell lysates were immunoblotted for
the indicated proteins.
(TIF)
Figure S3 Depletion of Cdh1 overcomes ER stress-
induced G1 delay. (A) DNA content of empty vector-transfected
or Cdh1-KD cells treated with DMSO or 2.5 mg/ml TM for 8 h
were analyzed by flow cytometry. Representative FACS histo-
grams show cell cycle distribution of DMSO-treated cells (red) and
TM-treated cells (blue). (B) DNA content of empty vector-
transfected or Cdh1-KD cells treated with DMSO or 1 mg/ml
TM for 16 h were analyzed by flow cytometry. Representative
FACS histograms are shown. Refer to Figure 2 for quantification
of increase in G1 population after TM treatment.
(TIF)
Figure S4 Cell cycle distribution of cells treated with
TM alone or together with the proteasome inhibitor
MG-132. (A) HeLa cells were treated with DMSO or 0.5 mg/ml
TM and cell cycle distribution was analyzed by FACS for a sample
of these cells. (B) HeLa cells were treated with 0.5 mg/ml TM plus
5 mM MG-132 for 16 h and cell cycle distribution was determined
by FACS for a sample of these cells. (C) Quantification of changes
in the percentage of G1 and G2/M populations following TM
treatment alone (A) or together with MG-132 (B), normalized to
the percentage of G1 or G2/M cells in the respective DMSO-
treated samples (A). Refer to Figure 3A for the biochemical
analysis performed using lysates prepared from these cells.
(TIF)
Figure S5 APC/C
Cdh1 does not mediate degradation of
Emi1 upon ER stress. Empty vector-transfected or Cdh1-KD
cells were treated with DMSO or 0.5 mg/ml TM for 16 h. Total
cell lysates were immunoblotted with the indicated antibodies.
(TIF)
Figure S6 Overexpression of Emi1 partially rescued ER
stress-dependent downregulation of APC/C
Cdh1 sub-
strates. Empty vector-transfected or Cdh1-KD cells were treated
with DMSO or 2.5 mg/ml TM for 2.5 h, 5 h, and 8 h. Total cell
lysates were immunoblotted with the indicated antibodies.
(TIF)
Figure S7 Cdh1 depletion enhanced susceptibility to ER
stress-induced cell death. Representative FACS histograms of
empty vector-transfected and Cdh1-KD cells treated with DMSO
or 0.5 mg/ml TM for 9 h, 12 h, and 24 h. Refer to the
quantification of sub-G1 (cells with less than 2 N DNA content)
in Figure 4D.
(TIF)
Figure S8 Sensitivity to ER stress-induced cell death in
the absence of Cdh1 is not mediated by JNK or CDKs.
Empty vector-transfected or Cdh1-KD cells were treated with
DMSO, 0.5 mg/ml TM alone, or 0.5 mg/ml TM plus either
10 mM JNK inhibitor SP600125 (SP) or pan-CDK inhibitor
roscovitine (Rosc). Graphs show quantification of sub-G1
population in cells treated with the indicated drugs for 8 h,
12 h, and 24 h by flow cytometry.
(TIF)
Figure S9 ER stress downregulates the protein level of
APC/C
Cdh1 substrates in HFF-1 cells. HFF-1 cells were
treated with DMSO or 1 mg/ml of TM for 16 h. Total cell lysates
were immunoblotted for the indicated endogenous proteins.
(TIF)
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